(Tiper Stock Exchange) – Health Italy closed the first quarter of the year with total revenue equal to 8.65 million, almost stable (+0.2%) compared to the first quarter of 2022 (8.63 million), with a contribution respectively of 73% from the “Healthcare and Services” division, 24% from the “Medical services” division, 2% from the ” Nutraceutical & Cosmeceutical” and 1% of the “Real Estate” division.
EBITDA is equal to 1.43 millionshows a 3.5% increase compared to the first quarter of 2022. The EBITDA Margin stood at 16.7% of operating revenues, compared to 16.3% in the first quarter of 2022. The excellent cost containment strategy allowed an improvement of around 40 basis points on the profitability side.
“In continuity with the results obtained in 2022, this first quarter of 2023 also shows stable or growing economic indicators compared to last year”, he says Livia LeafChief Executive Officer of Health Italia, adding “we are a solid company that continues along its growth path within a sector, that of supplementary healthcare and welfare, in constant evolution and expansion and in which we aim to play an increasingly important, thanks to an innovative approach and the effectiveness and quality of the services we provide to our customers”.